​

Evaxion Biotech (EVAX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

EVAX Stock Forecast

Evaxion Biotech (EVAX) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $13.50, with a high of $16.00 and a low of $11.00. This represents a 111.27% increase from the last price of $6.39.

- $4 $8 $12 $16 $20 High: $16 Avg: $13.5 Low: $11 Last Closed Price: $6.39

EVAX Stock Rating

Evaxion Biotech stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

EVAX Price Target Upside V Benchmarks

TypeNameUpside
StockEvaxion Biotech111.27%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-22
Avg Price Target-$13.50$13.50
Last Closing Price$6.39$6.39$6.39
Upside/Downside-111.27%111.27%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-2---2
Nov, 2512---3
Oct, 2511---2
Sep, 2511---2
Aug, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 20, 2025Thomas FlatenLake Street$11.00$7.1454.06%72.14%
Sep 25, 2025H.C. Wainwright$16.00$4.53253.20%150.39%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 10, 2025H.C. WainwrightBuyBuyhold
Oct 20, 2025Lake StreetBuyBuyhold
Oct 20, 2025H.C. WainwrightBuyBuyhold
Sep 25, 2025H.C. WainwrightBuyBuyhold
Sep 20, 2024H.C. WainwrightBuyBuyhold
Nov 17, 2022OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$-45 $-35 $-25 $-15 $-5 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-8.11-----
Avg Forecast$-38.67$-4.10$-7.86$2.76$0.25$3.30
High Forecast$-35.34$-1.53$-0.98$3.22$0.29$3.80
Low Forecast$-42.00$-6.67$-14.73$2.30$0.21$2.80
Surprise %-79.03%-----

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$73.11K-----
Avg Forecast$73.00K$4.48M$7.92M$26.55M$26.67M$85.94M
High Forecast$81.53K$5.71M$8.85M$29.65M$29.78M$95.99M
Low Forecast$64.47K$3.24M$7.00M$23.45M$23.55M$75.89M
Surprise %0.15%-----

Net Income Forecast

$-600M $-460M $-320M $-180M $-40M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-22.16M-----
Avg Forecast$-528.49M$-56.04M$-107.38M$37.72M$3.35M$45.10M
High Forecast$-482.99M$-20.85M$-13.38M$43.94M$3.94M$51.96M
Low Forecast$-573.99M$-91.23M$-201.39M$31.50M$2.90M$38.25M
Surprise %-95.81%-----

EVAX Forecast FAQ

Is Evaxion Biotech stock a buy?

Evaxion Biotech stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Evaxion Biotech is a favorable investment for most analysts.

What is Evaxion Biotech's price target?

Evaxion Biotech's price target, set by 4 Wall Street analysts, averages $13.5 over the next 12 months. The price target range spans from $11 at the low end to $16 at the high end, suggesting a potential 111.27% change from the previous closing price of $6.39.

How does Evaxion Biotech stock forecast compare to its benchmarks?

Evaxion Biotech's stock forecast shows a 111.27% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Evaxion Biotech over the past three months?

  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Evaxion Biotech’s EPS forecast?

Evaxion Biotech's average annual EPS forecast for its fiscal year ending in December 2024 is $-4.1, marking a -49.45% decrease from the reported $-8.11 in 2023. Estimates for the following years are $-7.86 in 2025, $2.76 in 2026, $0.25 in 2027, and $3.3 in 2028.

What is Evaxion Biotech’s revenue forecast?

Evaxion Biotech's average annual revenue forecast for its fiscal year ending in December 2024 is $4.48M, reflecting a 6028.04% increase from the reported $73.11K in 2023. The forecast for 2025 is $7.92M, followed by $26.55M for 2026, $26.67M for 2027, and $85.94M for 2028.

What is Evaxion Biotech’s net income forecast?

Evaxion Biotech's net income forecast for the fiscal year ending in December 2024 stands at $-56.038M, representing an 152.89% increase from the reported $-22.159M in 2023. Projections indicate $-107M in 2025, $37.72M in 2026, $3.35M in 2027, and $45.1M in 2028.